Silvina Natalini Martínez (Silvina Natalini)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Aortic Dissection

Respiratory Syncytial Virus

Top Venues

Paediatric drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Fernando Claudio Ferrero, Chien-Yu Lin, Johannes Liese, Kleber Giovanni Luz, Tatyana Stoeva, Agnes Nemeth, Manuel Gijón, Christina Calvo, Silvina Natalini Martínez, Teck-Hock Toh, Sofie Deleu, Bohang Chen, Sarah Rusch, Beatriz López Sánchez, Illse Leipoldt, Leen Vijgen, Dymphy Huntjens, Tristan Baguet, Kristi Bertzos, Mohamed Gamil, Marita Stevens, null null
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus. Paediatric drugs (2024)
Fernando Claudio Ferrero, Chien-Yu Lin, Johannes Liese, Kleber Giovanni Luz, Tatyana Stoeva, Agnes Nemeth, Manuel Gijón, Christina Calvo, Silvina Natalini Martínez, Teck-Hock Toh, Sofie Deleu, Bohang Chen, Sarah Rusch, Beatriz López Sánchez, Illse Leipoldt, Leen Vijgen, Dymphy Huntjens, Tristan Baguet, Kristi Bertzos, Mohamed Gamil, Marita Stevens, null null
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus. Paediatric drugs 26 (4) (2024)
Fernando Claudio Ferrero, Chien-Yu Lin, Johannes Liese, Kleber Giovanni Luz, Tatyana Stoeva, Agnes Nemeth, Manuel Gijón, Christina Calvo, Silvina Natalini Martínez, Teck-Hock Toh, Sofie Deleu, Bohang Chen, Sarah Rusch, Beatriz López Sánchez, Illse Leipoldt, Leen Vijgen, Dymphy Huntjens, Tristan Baguet, Kristi Bertzos, Mohamed Gamil, Marita Stevens, null null
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus. Paediatric drugs 26 (4) (2024)
María Jesús López Fernández, Silvia Narejos, Antoni Castro, José María Echave-Sustaeta, Maria Jose Forner, Eunate Arana-Arri, José Molto, Laia Bernad, Raúl Pérez-Caballero, Julia G Prado, Dàlia Raïch-Regué, Rytis Boreika, Nuria Izquierdo-Useros, Benjamin Trinitè, Julian Blanco, Joan Puig-Barbera, Silvina Natalini Martínez
Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results. Vaccines 12 (8) (2024)
Fernando Claudio Ferrero, Chien-Yu Lin, Johannes Liese, Kleber Giovanni Luz, Tatyana Stoeva, Agnes Nemeth, Manuel Gijón, Christina Calvo, Silvina Natalini Martínez, Teck-Hock Toh, Sofie Deleu, Bohang Chen, Sarah Rusch, Beatriz López Sánchez, Illse Leipoldt, Leen Vijgen, Dymphy Huntjens, Tristan Baguet, Kristi Bertzos, Mohamed Gamil, Marita Stevens, null null
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus. Paediatric drugs 26 (4) (2024)